IGNITE Launches Efforts to Stop the Spread of COVID-19 Pandemic
VAUGHAN, Ontario, April 28, 2020 (GLOBE NEWSWIRE) — IGNITE International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”), a global […]
Selecta Biosciences Appoints Dr. Goran Ando to its Board of Directors
WATERTOWN, Mass., April 28, 2020 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking […]
Lightbridge CEO Seth Grae Issues Letter to Shareholders
RESTON, Va., April 28, 2020 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge,” or the “Company”) (NASDAQ: LTBR), an advanced nuclear fuel […]
Franklin Electric Reports First Quarter 2020 Sales and Earnings and Provides an Update on Effects of the Global Pandemic
FORT WAYNE, Ind., April 28, 2020 (GLOBE NEWSWIRE) — Franklin Electric Co., Inc. (NASDAQ: FELE) reported first quarter 2020 GAAP […]
BioDelivery Sciences to Report First Quarter 2020 Financial Results on May 7, 2020
RALEIGH, N.C., April 28, 2020 (GLOBE NEWSWIRE) — BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company […]
VERB Begins Japan Operations as Part of International Expansion Plan Tapping into a Multi-Billion-Dollar Market Opportunity
NEWPORT BEACH, Calif. and SALT LAKE CITY, Utah, April 28, 2020 (GLOBE NEWSWIRE) — VERB Technology Company, Inc. (NASDAQ: VERB) […]
Zogenix to Release First Quarter 2020 Financial Results and Host Conference Call and Webcast on May 5
EMERYVILLE, Calif., April 28, 2020 (GLOBE NEWSWIRE) — Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, […]
Vaxart Announces Corporate Update for First Quarter 2020
Preparations for the Manufacturing of GMP Vaccine at Emergent BioSolutions OngoingVaxart is Participating in Maxim’s Infectious Disease Virtual Conference on […]
Cidara Therapeutics to Participate in Antifungal and COVID-19 Therapeutics Panels at Maxim Group’s Infectious Disease Virtual Conference
SAN DIEGO, April 28, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a clinical-stage biotechnology company focused on the […]
Vir Biotechnology to Provide Corporate Update and Report First Quarter 2020 Financial Results on May 12, 2020
SAN FRANCISCO, April 28, 2020 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating […]
